Treace Medical Concepts Stock (NASDAQ:TMCI)

Headquartered in Ponte Vedra Beach, Florida, Treace Medical Concepts, Inc. is an orthopedic medical device enterprise that specializes in the development, manufacturing, and commercialization of surgical tools for foot and ankle specialists throughout the United States. A cornerstone of its product line is the Lapiplasty procedure, which enables surgeons to comprehensively correct bunions in all three dimensions, thereby offering patients significant cosmetic and medical benefits. The firm also provides the Lapiplasty Mini-Incision precision system. Furthermore, its portfolio includes instruments designed to facilitate various ancillary surgical procedures, such as akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, autograft bone harvesting, and MTP fusion. Treace Medical Concepts, Inc. was established in 2013.